vs
微芯科技（MCHP）与Insulet Corporation（PODD）财务数据对比。点击上方公司名可切换其他公司
微芯科技的季度营收约是Insulet Corporation的1.5倍（$1.2B vs $783.7M），Insulet Corporation净利率更高（13.0% vs 5.3%，领先7.7%），Insulet Corporation同比增速更快（31.2% vs 15.6%），微芯科技自由现金流更多（$318.9M vs $48.2M），过去两年Insulet Corporation的营收复合增速更高（33.2% vs -5.4%）
微芯科技（Microchip Technology）是美国知名上市半导体企业，主营微控制器、混合信号芯片、模拟芯片及闪存知识产权（Flash-IP）相关集成电路的研发、生产与销售，产品覆盖工业控制、汽车电子、消费电子、物联网等众多领域，在全球半导体细分市场拥有领先地位。
Insulet Corporation是深耕糖尿病治疗领域的医疗器械企业，核心产品为胰岛素泵，通过持续皮下输注胰岛素的疗法为患者给药。其产品通常由泵主体、一次性胰岛素储药仓，以及包含皮下植入套管和连接管路的一次性输注套件构成，满足不同患者的治疗需求。
MCHP vs PODD — 直观对比
营收规模更大
MCHP
是对方的1.5倍
$783.7M
营收增速更快
PODD
高出15.6%
15.6%
净利率更高
PODD
高出7.7%
5.3%
自由现金流更多
MCHP
多$270.7M
$48.2M
两年增速更快
PODD
近两年复合增速
-5.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $783.7M |
| 净利润 | $62.7M | $101.6M |
| 毛利率 | 59.6% | 72.6% |
| 营业利润率 | 12.8% | 18.7% |
| 净利率 | 5.3% | 13.0% |
| 营收同比 | 15.6% | 31.2% |
| 净利润同比 | 217.0% | 0.9% |
| 每股收益（稀释后） | $0.06 | $1.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MCHPPODD
| Q4 25 | $1.2B | $783.7M | ||
| Q3 25 | $1.1B | $706.3M | ||
| Q2 25 | $1.1B | $649.1M | ||
| Q1 25 | $970.5M | $569.0M | ||
| Q4 24 | $1.0B | $597.5M | ||
| Q3 24 | $1.2B | $543.9M | ||
| Q2 24 | $1.2B | $488.5M | ||
| Q1 24 | $1.3B | $441.7M |
净利润MCHPPODD
| Q4 25 | $62.7M | $101.6M | ||
| Q3 25 | $41.7M | $87.6M | ||
| Q2 25 | $-18.6M | $22.5M | ||
| Q1 25 | $-154.6M | $35.4M | ||
| Q4 24 | $-53.6M | $100.7M | ||
| Q3 24 | $78.4M | $77.5M | ||
| Q2 24 | $129.3M | $188.6M | ||
| Q1 24 | $154.7M | $51.5M |
毛利率MCHPPODD
| Q4 25 | 59.6% | 72.6% | ||
| Q3 25 | 55.9% | 72.2% | ||
| Q2 25 | 53.6% | 69.7% | ||
| Q1 25 | 51.6% | 71.9% | ||
| Q4 24 | 54.7% | 72.1% | ||
| Q3 24 | 57.4% | 69.3% | ||
| Q2 24 | 59.4% | 67.7% | ||
| Q1 24 | 59.6% | 69.5% |
营业利润率MCHPPODD
| Q4 25 | 12.8% | 18.7% | ||
| Q3 25 | 7.8% | 16.7% | ||
| Q2 25 | 3.0% | 18.7% | ||
| Q1 25 | -10.3% | 15.6% | ||
| Q4 24 | 3.0% | 18.3% | ||
| Q3 24 | 12.6% | 16.2% | ||
| Q2 24 | 17.7% | 11.2% | ||
| Q1 24 | 19.1% | 12.9% |
净利率MCHPPODD
| Q4 25 | 5.3% | 13.0% | ||
| Q3 25 | 3.7% | 12.4% | ||
| Q2 25 | -1.7% | 3.5% | ||
| Q1 25 | -15.9% | 6.2% | ||
| Q4 24 | -5.2% | 16.9% | ||
| Q3 24 | 6.7% | 14.2% | ||
| Q2 24 | 10.4% | 38.6% | ||
| Q1 24 | 11.7% | 11.7% |
每股收益（稀释后）MCHPPODD
| Q4 25 | $0.06 | $1.42 | ||
| Q3 25 | $0.03 | $1.24 | ||
| Q2 25 | $-0.09 | $0.32 | ||
| Q1 25 | $-0.29 | $0.50 | ||
| Q4 24 | $-0.10 | $1.38 | ||
| Q3 24 | $0.14 | $1.08 | ||
| Q2 24 | $0.24 | $2.59 | ||
| Q1 24 | $0.29 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $250.7M | — |
| 总债务越低越好 | $5.4B | $930.8M |
| 股东权益账面价值 | $6.6B | $1.5B |
| 总资产 | $14.3B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.82× | 0.61× |
8季度趋势，按日历期对齐
现金及短期投资MCHPPODD
| Q4 25 | $250.7M | — | ||
| Q3 25 | $236.8M | — | ||
| Q2 25 | $566.5M | — | ||
| Q1 25 | $771.7M | — | ||
| Q4 24 | $586.0M | — | ||
| Q3 24 | $286.1M | — | ||
| Q2 24 | $315.1M | — | ||
| Q1 24 | $319.7M | — |
总债务MCHPPODD
| Q4 25 | $5.4B | $930.8M | ||
| Q3 25 | $5.4B | $934.9M | ||
| Q2 25 | $5.5B | $939.0M | ||
| Q1 25 | $5.6B | $1.6B | ||
| Q4 24 | $6.7B | $1.3B | ||
| Q3 24 | $6.4B | $1.4B | ||
| Q2 24 | $6.2B | $1.4B | ||
| Q1 24 | $6.0B | $1.4B |
股东权益MCHPPODD
| Q4 25 | $6.6B | $1.5B | ||
| Q3 25 | $6.7B | $1.4B | ||
| Q2 25 | $6.9B | $1.5B | ||
| Q1 25 | $7.1B | $1.3B | ||
| Q4 24 | $6.0B | $1.2B | ||
| Q3 24 | $6.3B | $1.1B | ||
| Q2 24 | $6.4B | $998.4M | ||
| Q1 24 | $6.7B | $790.7M |
总资产MCHPPODD
| Q4 25 | $14.3B | $3.2B | ||
| Q3 25 | $14.5B | $3.0B | ||
| Q2 25 | $15.0B | $3.5B | ||
| Q1 25 | $15.4B | $3.5B | ||
| Q4 24 | $15.6B | $3.1B | ||
| Q3 24 | $15.6B | $3.0B | ||
| Q2 24 | $15.8B | $2.9B | ||
| Q1 24 | $15.9B | $2.6B |
负债/权益比MCHPPODD
| Q4 25 | 0.82× | 0.61× | ||
| Q3 25 | 0.80× | 0.68× | ||
| Q2 25 | 0.80× | 0.64× | ||
| Q1 25 | 0.80× | 1.21× | ||
| Q4 24 | 1.12× | 1.07× | ||
| Q3 24 | 1.02× | 1.21× | ||
| Q2 24 | 0.96× | 1.36× | ||
| Q1 24 | 0.90× | 1.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $341.4M | $183.3M |
| 自由现金流经营现金流 - 资本支出 | $318.9M | $48.2M |
| 自由现金流率自由现金流/营收 | 26.9% | 6.2% |
| 资本支出强度资本支出/营收 | 1.9% | 17.2% |
| 现金转化率经营现金流/净利润 | 5.44× | 1.80× |
| 过去12个月自由现金流最近4个季度 | $819.9M | $377.7M |
8季度趋势，按日历期对齐
经营现金流MCHPPODD
| Q4 25 | $341.4M | $183.3M | ||
| Q3 25 | $88.1M | $125.7M | ||
| Q2 25 | $275.6M | $196.5M | ||
| Q1 25 | $205.9M | $63.8M | ||
| Q4 24 | $271.5M | $147.7M | ||
| Q3 24 | $43.6M | $98.5M | ||
| Q2 24 | $377.1M | $96.5M | ||
| Q1 24 | $430.0M | $87.6M |
自由现金流MCHPPODD
| Q4 25 | $318.9M | $48.2M | ||
| Q3 25 | $51.6M | $100.1M | ||
| Q2 25 | $257.7M | $177.9M | ||
| Q1 25 | $191.7M | $51.5M | ||
| Q4 24 | $253.4M | $94.1M | ||
| Q3 24 | $22.8M | $71.8M | ||
| Q2 24 | $304.2M | $74.0M | ||
| Q1 24 | $389.9M | $65.5M |
自由现金流率MCHPPODD
| Q4 25 | 26.9% | 6.2% | ||
| Q3 25 | 4.5% | 14.2% | ||
| Q2 25 | 24.0% | 27.4% | ||
| Q1 25 | 19.8% | 9.1% | ||
| Q4 24 | 24.7% | 15.7% | ||
| Q3 24 | 2.0% | 13.2% | ||
| Q2 24 | 24.5% | 15.1% | ||
| Q1 24 | 29.4% | 14.8% |
资本支出强度MCHPPODD
| Q4 25 | 1.9% | 17.2% | ||
| Q3 25 | 3.2% | 3.6% | ||
| Q2 25 | 1.7% | 2.9% | ||
| Q1 25 | 1.5% | 2.2% | ||
| Q4 24 | 1.8% | 9.0% | ||
| Q3 24 | 1.8% | 4.9% | ||
| Q2 24 | 5.9% | 4.6% | ||
| Q1 24 | 3.0% | 5.0% |
现金转化率MCHPPODD
| Q4 25 | 5.44× | 1.80× | ||
| Q3 25 | 2.11× | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | — | 1.80× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | 0.56× | 1.27× | ||
| Q2 24 | 2.92× | 0.51× | ||
| Q1 24 | 2.78× | 1.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MCHP
| Mixed Signal Microcontrollers | $586.5M | 49% |
| Analog | $322.9M | 27% |
| Other Product Line | $276.6M | 23% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
